The global market for Feline Hyperthyroidism Treatments is poised for significant growth as awareness of this common endocrine disorder in cats increases, and advancements in treatment options continue to improve. According to Market Intelo's latest report, the global market for feline hyperthyroidism treatments was valued at USD 1.1 billion in 2024 and is projected to grow at a CAGR of 8.4% from 2024 to 2032, reaching a market size of USD 2.1 billion by 2032. This growth is being driven by rising pet healthcare spending, a better understanding of feline hyperthyroidism, and a growing focus on effective, long-term treatment options.